Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.

31/Atlas is a mysterious object that has sparked speculation about aliens and scientific fascination because it comes from a different solar system. 3I/Atlas shares compositional traits with "dwarf ...

Illumina on Tuesday unveiled what it calls the world’s largest functional cell dictionary that, when paired with artificial intelligence, will help accelerate drug discovery. Dubbed the Billion Cell ...

The discovery of the interstellar comet 3I/ATLAS was supposed to be a triumph of open science, a rare chance to study ...

The Atlas will enable the validation of genetic targets and training of AI models at unprecedented scale SAN DIEGO, Jan. 13, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today introduced the ...

Jan 13 (Reuters) - Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help accelerate drug discovery through artificial intelligence. The company said it was ...

AI across the pharmaceutical ecosystem. The Illumina Billion Cell Atlas is the first tranche of its program to build a 5 billion cell atlas over three years, and will be the most comprehensive map of ...

SAN DIEGO, Jan. 13, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today introduced the world's largest genome-wide genetic perturbation dataset, being built to accelerate drug discovery through ...